Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Importance of He4 and Ca 125 in Overall Survival and Recurrence-Free Survival of Endometrial Cancer Publisher



Gilani MM1 ; Mehr SGD2 ; Mousavi A1 ; Akhavan S1 ; Sheikhhasani S1 ; Zamani N3 ; Sahebi L4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Oncologic Gynecology, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Obstetrics and Gynecology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
  3. 3. Department of Gynecology and Obstetrics, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Family Health Research Institute, Maternal-Fetal and Neonatal Research Center, Tehran University of Medical Science, Tehran, Iran

Source: International Journal of Women's Health and Reproduction Sciences Published:2022


Abstract

Objectives: The present study aimed to assess the significance of human epididymis protein 4 (HE4) and cancer antigen 125 (CA 125) in the overall survival (OS) and the recurrence survival of endometrial cancer. Materials and Methods: The study was conducted on 99 patients with a mean age of 53±64. The patients were all cases with a definitive diagnosis of endometrial cancer. With regard to the histology and the surface measurement, the HE4 and CA 125 were both confirmed within 1 to 2 week(s) prior to hysterectomy by implementing the standard-procedure treatment of extra facial total hysterectomy and bilateral salpingo-oophorectomy with selective pelvic and para-aortic node dissection. Then, risk-assessment for possible recurrence (Mayo criteria) was carried out as well. Patients with the variables of HE4 and CA 125 in the upper third (66th) percentiles were grouped as high-risk. Finally, the data were analyzed using SPPS 23, and P <0.05 was considered statistically significant. Results: The mean (SE) of OS among patients with the serum CA 125 of ≤22 kU/L and higher 22 kU/L was 47.97 (±2.58) and 41.78 (3.75) months (P = 0.466). In addition, the mean (SE) of OS in patients with the serum HE4 level of ≤ 98 ρmol/L and >98 ρmol/L was 50.14 (2.06) and 38.54 (3.74), respectively. The log-rank test revealed a substantial difference between low-and high-risk groups by HE4 (χ2=4.98, P = 0.025). Accordingly, there is no significant difference between recurrence-free survival (RFS) with CA 125 (P = 0.264) and HE4 (P = 0.114), respectively. Conclusions: In general, the serum HE4 level is a significant independent prognostic factor for OS in endometrial cancer and is useful in survival studies. © 2022, Aras Part Medical International Press. All rights reserved.
Related Docs
1. The Utility of Ca125 and He4 in Patients Suffering From Endometrial Cancer, International Journal of Women's Health and Reproduction Sciences (2020)
2. Utility of Tumor Marker He4 and Ca125 to Predict Staging in Endometrioid Adenocarcinoma of the Uterus, Tehran University Medical Journal (2015)
3. The Prognostic Role of Preoperative Serum Ca125 Levels in Patients With Advanced Endometrial Carcinoma, Cancer Biomarkers (2017)
4. He4, a New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression, Iranian Journal of Pathology (2021)
Experts (# of related papers)
View all Related Experts
Narges Zamani (3)
Mamak Shariat (1)